GGrantIndex
Sort

46,585 grants matching heart failure

Docosahexaenoic Acid for Treatment of Heart Failure

$660,348
William C Stanley · University Of Maryland Baltimore · P20 · FY2011 · HL

Off-label drugs in cardiology: evaluating age- and disease-appropriate therapies

$660,186
Nikki Gillum Posnack · Children'S Research Institute · R01 · FY2023 · HD

Individualized medicine to predict and prevent chemotherapy-related heart failure

$660,138
Nadine Norton · Mayo Clinic Jacksonville · R01 · FY2023 · HL

Understanding and Eliminating Oncogenic EGFR Signaling in Malignant Glioma

$660,126
Alain Charest · Tufts Medical Center · U01 · FY2012 · CA

Desmoplakinopathies: Integrated Pathophysiology and Therapeutics

$660,080
Stuart G Campbell · Yale University · R01 · FY2024 · HL

Novel roles of RNA modifications in the pathogenesis of pulmonary vascular remodeling and PAH

$660,077
You-Yang Zhao · Lurie Children'S Hospital Of Chicago · R01 · FY2025 · HL

Novel roles of RNA modifications in the pathogenesis of pulmonary vascular remodeling and PAH

$660,077
You-Yang Zhao · Lurie Children'S Hospital Of Chicago · R01 · FY2023 · HL

Role of IGF axis in pulmonary hypertension

$660,065
Allen D Everett · Johns Hopkins University · R01 · FY2023 · HL

IP3 receptor, NOX2 and calcium signaling domains in atrial physiology and pathophysiology

$660,039
Kathrin Banach · Rush University Medical Center · R01 · FY2024 · HL

Fortilin, CTNNA3, and the Heart

$660,031
Ken Fujise · University Of Washington · R01 · FY2024 · HL

Post-transcriptional regulation of cardiac hypertrophy

$660,023
Federica Accornero · Brown University · R01 · FY2024 · HL

Leveraging the ESRD Treatment Choices model to understand the benefits of home versus in-center dialysis

$660,010
Vahakn B Shahinian · University Of Michigan At Ann Arbor · R01 · FY2025 · DK

Hispanic Chronic Renal Insufficiency Cohort(CRIC) Study

$659,992
James P Lash · University Of Illinois At Chicago · R01 · FY2012 · DK

Building a kidney monitoring panel to guide therapy in resistant hypertension

$659,917
Rajesh Gupta · University Of Toledo Health Sci Campus · R01 · FY2025 · HL

Social and geographic predictors of heterogeneity in cardiovascular risk in Afric

$659,865
Ana V Diez Roux · University Of Michigan At Ann Arbor · P60 · FY2007 · MD

Cardiac MRI for Reperfusion Spatial Mapping to Improve Heart Failure Outcomes

$659,820
Kim-Lien T Nguyen · University Of California Los Angeles · R01 · FY2024 · HL

Cardiovascular Risk of Antiretroviral Therapy Drugs in HIV

$659,783
Jasimuddin Ahamed · Oklahoma Medical Research Foundation · R01 · FY2024 · HL

Myocardial remuscularization by cardiac patch delivery of epicardial FSTL1 and CCND2 overexpressing cardiomyocytes

$659,768
Jianyi Zhang · University Of Alabama At Birmingham · R01 · FY2024 · HL

Human iPSC-derived atrial cardiomyocytes to model atrial fibrillation in a dish

$659,665
Dawood Darbar · University Of Illinois At Chicago · R01 · FY2020 · HL

Safety and modulation of ABCC9 pathways by nicorandil for the treatment of hippocampal sclerosis of aging (SMArT–HS)

$659,649
Gregory A Jicha · University Of Kentucky · R01 · FY2025 · AG

Enhancing Liver Cancer Treatment With Image-Guided Magnetic Hyperthermia

$659,622
Eleni A. Liapi · Johns Hopkins University · R01 · FY2016 · CA

A Novel High Throughput Assay for Ion Channel Modulators

$659,605
Chanxpress, Inc. · R44 · FY2005 · HL

Fibroblast targeting for myocardial repair

$659,587
Francis G Spinale · University Of South Carolina At Columbia · R01 · FY2025 · HL

Ischemia/Reperfusion injury and Myocardial edema

$659,514
Michael Simons · Yale University · R01 · FY2025 · HL

Genetically Informed Smoking Cessation Trial

$659,514
Li-Shiun Chen · Washington University · R01 · FY2017 · DA